ARS Pharmaceuticals (SPRY) Selling, General & Administrative Expenses

Annual SGA

$47.28 M
+$28.83 M+156.20%

December 31, 2023


Summary


Performance

SPRY SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYexpensesmetrics:

Quarterly SGA

$19.28 M
+$10.34 M+115.57%

September 30, 2024


Summary


Performance

SPRY Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYexpensesmetrics:

TTM SGA

-$600.25 M
-$49.10 M-8.91%

September 30, 2024


Summary


Performance

SPRY TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

SPRY Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+156.2%+115.6%-1651.0%
3 y3 years+1016.8%+115.6%-1651.0%
5 y5 years+1016.8%+115.6%-1651.0%

SPRY Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+908.8%at high+724.3%-1320.5%at low
5 y5-yearat high+1016.8%at high+724.3%-1320.5%at low
alltimeall timeat high+1016.8%at high+724.3%-1320.5%at low

ARS Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.28 M(+115.6%)
$43.01 M(+11.1%)
Jun 2024
-
$8.94 M(+12.4%)
$38.70 M(-10.1%)
Mar 2024
-
$7.96 M(+16.7%)
$43.06 M(-8.9%)
Dec 2023
$47.28 M
$6.82 M(-54.4%)
$47.28 M(-7.6%)
Sep 2023
-
$14.98 M(+12.6%)
$51.20 M(+30.8%)
Jun 2023
-
$13.30 M(+9.2%)
$39.15 M(+38.3%)
DateAnnualQuarterlyTTM
Mar 2023
-
$12.18 M(+13.5%)
$28.30 M(+53.3%)
Dec 2022
$18.46 M(+293.8%)
$10.73 M(+266.8%)
$18.46 M(+139.0%)
Sep 2022
-
$2.93 M(+19.0%)
$7.72 M(+61.0%)
Jun 2022
-
$2.46 M(+5.1%)
$4.80 M(+105.1%)
Mar 2022
-
$2.34 M
$2.34 M
Dec 2021
$4.69 M(+10.7%)
-
-
Dec 2020
$4.23 M
-
-

FAQ

  • What is ARS Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual SGA year-on-year change?
  • What is ARS Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly SGA year-on-year change?
  • What is ARS Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals TTM SGA year-on-year change?

What is ARS Pharmaceuticals annual SGA?

The current annual SGA of SPRY is $47.28 M

What is the all time high annual SGA for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual SGA is $47.28 M

What is ARS Pharmaceuticals annual SGA year-on-year change?

Over the past year, SPRY annual SGA has changed by +$28.83 M (+156.20%)

What is ARS Pharmaceuticals quarterly SGA?

The current quarterly SGA of SPRY is $19.28 M

What is the all time high quarterly SGA for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly SGA is $19.28 M

What is ARS Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, SPRY quarterly SGA has changed by +$10.34 M (+115.57%)

What is ARS Pharmaceuticals TTM SGA?

The current TTM SGA of SPRY is -$600.25 M

What is the all time high TTM SGA for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high TTM SGA is -$42.26 M

What is ARS Pharmaceuticals TTM SGA year-on-year change?

Over the past year, SPRY TTM SGA has changed by -$638.95 M (-1651.03%)